NCT00138619View on ClinicalTrials.gov

Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

478

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

vildagliptin

Trial Locations (2)

07936

Novartis Pharmaceuticals, East Hanover

Unknown

Investigative Centers

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY